Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Ginkgo fails important memory test, according to study in JAMA

21.08.2002


Ginkgo biloba has no beneficial effect on memory and related mental functions of healthy older adults when taken following manufacturer’s instructions, according to a study in the Aug. 21st issue of the Journal of the American Medical Association conducted by researchers at Williams College in Williamstown, Mass. and The Memory Clinic in Bennington, Vt.



The study was designed and conducted by the paper’s lead author, Paul R. Solomon, Ph.D., professor of psychology and founding chair of the college’s Neuroscience Program, Richard D. De Veaux, Ph.D., professor of statistics, and three students: Felicity Adams, Amanda Silver, and Jill Zimmer.

Extract from leaves of the tree Ginkgo biloba is marketed worldwide as an enhancer of memory and other mental functions. In 1998, $310 million dollars worth was sold in the U.S. alone.


Researchers identified 230 volunteers over the age of 60 who were physically and mentally healthy. They gave them 14 tests of learning, memory, and attention and concentration, and had them and their companions (e.g. spouses, partners, close friends) rate the participants’ mental functions on subjective scales.

Participants were then randomly divided into two groups: one to take gingko and one placebo. The study was double-blind; neither the participants nor the researchers knew who was taking ginkgo and who was taking placebo.

The manufacturer claims beneficial effects can be noticed after four weeks. After six weeks, participants in the study retook the 14 standardized tests and they and their companions re-rated participants’ mental functions. There were no significant differences between those taking ginkgo and those taking placebo on any of the objective or subjective measures.

"Many of our patients and their families who are seen at the Memory Clinic in Bennington have asked whether ginkgo could slow or reverse the effects of aging on memory," Solomon said. "Since there were no scientifically rigorous studies of this, we decided to conduct a study of ginkgo on memory. The results indicate that when taken following the manufacturer’s instructions, ginkgo provides no measurable benefit in memory, attention, or concentration in healthy older adults. We hope others will now further test ginkgo and other vitamins and nutrients to see if they really provide the benefits they claim.

"As with any over-the-counter substance, people taking ginkgo, or thinking of taking it, have to decide for themselves what’s right but they owe it to themselves to inform that decision with knowledge of scientific studies. They also need to consider cost and possible side effects, especially if taken with medication or other substances."

Other researchers welcomed the study. "It is critically important that claims of effectiveness of all treatments, including natural products, be supported by scientifically valid results from well controlled clinical trials," said Steven H. Ferris, Ph.D., Friedman Professor for Alzheimer’s Disease at NYU School of Medicine and executive director of the Silberstein Institute for Aging and Dementia. "This important, very well conducted clinical trial clearly calls into question previously unsubstantiated claims that Ginkgo biloba improves mental function in older people."


The study was supported by grants from the National Institute on Aging, the Howard Hughes Medical Institute, and the Essel Foundation.

Editors: Paul Solomon will be available for individual interviews Aug. 20 from 9 a.m. to 3 p.m. in New York City at The Williams Club (24 East 39th Street). To schedule an interview, on the 20th or any day, contact Cynthia Murphy, Executive Director of the Memory Clinic (cell phone: 413-281-0576).

Paul Solomon | EurekAlert!

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>